PTX
Click for more information
6.41% 4.2¢ prescient therapeutics limited

Ann: Third complete response in PTX-200 AML Trial, page-358

  1. dalts66
    4,317 Posts.
    lightbulb Created with Sketch. 2019
    clock Created with Sketch.
    21/08/21
    21:47
    Post #: 55471844
    Here it is.

    It was the AML trial prior to the expansion with new treatment protocol.
    Also have a look at the Nov 19 announcements re the breast cancer trial. 2 CRs and a 91% response rate there.

    This is a very promising drug. Just like the others
    Likes Created with Sketch. 18  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.2¢ 		Change
0.003(6.41%) 		Mkt cap ! $33.42M
Open High Low Value Volume
4.1¢ 4.2¢ 4.1¢ $3.969K 96.19K

Buyers (Bids)

No. Vol. Price($)
1 366 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 221176 2
View Market Depth
Last trade - 15.33pm 04/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.